Molecular Structure of Tuberculosis Efflux Pump Reveals How Bacteria Resist Key Antibiotic

Tuberculosis case diagnosed on Texas State campus

AUSTIN (KXAN) — A person at Texas State University, or TXST, was diagnosed with tuberculosis disease, according to a message shared with the campus. The Hays County Health Department informed the university of the diagnosis Tuesday. The person was at the San Marcos campus. “While the chance of exposure and infection is minimal, we wanted to make you aware,” the message said. TXST wouldn't specify if the person diagnosed was a student, staff memb…

Strategies for shortening tuberculosis therapy

In the absence of effective patient-stratification approaches, tuberculosis (TB) treatment relies on overtreating most patients to ensure high cure rates. Shortening treatment duration without compromising efficacy is therefore high on the agenda of the global TB community. While new and better drugs are certainly needed, we argue that innovative but rational treatment strategies, using both new and existing therapies, will help achieve this goa…

Texas State confirms tuberculosis case on campus

Texas State University officials confirmed that a person on the San Marcos campus has been diagnosed with tuberculosis.The Hays County Health Department informe

Molecular structure of tuberculosis efflux pump reveals how bacteria resist key antibiotic

Tuberculosis is the world's leading infectious cause of death, killing more than one million people each year. When the antibiotic bedaquiline was introduced in 2012, it was the first new tuberculosis drug in over 40 years. Bedaquiline quickly became the key drug in all standard drug-resistant tuberculosis regimens globally. Unfortunately, clinical Mycobacterium tuberculosis strains rapidly become resistant to bedaquiline, predominantly by overe…

Molecular structure of tuberculosis efflux pump reveals how bacteria resist key antibiotic - Tech and Science Post

Tuberculosis is the world’s leading infectious cause of death, killing more than one million people each year. When the antibiotic bedaquiline was introduced in 2012, it was the first new tuberculosis drug in over 40 years. Bedaquiline quickly became the key drug in all standard drug-resistant tuberculosis regimens globally. Unfortunately, clinical Mycobacterium tuberculosis strains rapidly become resistant to bedaquiline, predominantly by overe…